by Keishi Foecke | Feb 4, 2025 | Blog Post, PULSE Partner
In a recent op-ed for NJBIZ, Debbie Hart, President and CEO of PULSE Partner BioNJ, discusses how federal policy against mergers and acquisitions (M&A) could undermine New Jersey’s leadership in the life sciences. Read the op-ed below: As the “medicine chest of...
by Keishi Foecke | Jan 29, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Jan 22, 2025 | Blog Post
In the wake of the 43rd J.P. Morgan Healthcare Conference held last week, industry leaders underscored the essential role of mergers and acquisitions (M&A) in fueling America’s life sciences industry. In this annual spotlight on the life sciences industry, M&A...
